PALO ALTO, Calif., Feb. 25, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the South Florida Proton Therapy Institute, a Proton International facility, has joined the FlashForward™ Consortium. Now including 14 members, the consortium is focused on preclinical research, clinical implementation and advocacy efforts of Flash therapy, a new therapy representing an exciting and potentially promising new direction in the treatment of cancer.
Flash therapy is a non-invasive treatment using an external beam delivered in high doses, at ultra-high speeds (less than 1 second), and in one to three sessions. Working groups in the FlashForward Consortium will help identify preclinical study design for understanding this therapy, develop and share protocols that will enable a safe and quality clinical start for new users, and assist with regulatory and advocacy efforts. The first meeting of the consortium will be held March 8-9, 2019 in Atlanta, GA.
"Since announcing the FlashForward Consortium in October, we have received a strong positive industry response to this potential new therapy and the work of the Consortium," said Kolleen Kennedy, chief growth officer and president of Proton Therapy Solutions, Varian. "We are pleased to welcome the South Florida Proton Therapy Institute to this working group and we look forward to their contributions to this important research and development effort."
"We will soon be treating patients with proton therapy in South Florida and as one of the newest members of the FlashForward Consortium we are excited about the potential of Flash therapy in the future," said Dr. Tim Williams, medical director of South Florida Proton Therapy Institute.
"Proton International is pleased to have this facility involved in important programs such as this that could potentially lead to improved clinical solutions," said Chris Chandler, chief executive officer, Proton International.
Varian is a leader in developing and delivering cancer care solutions and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 7,000 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Director, Global Public Relations
+1 (650) 424-5630
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163